Searchable abstracts of presentations at key conferences in endocrinology

ea0056p1167 | Thyroid cancer | ECE2018

TSH level and risk of malignancy in patients with thyroid nodules with Bethesda IV Cytopathology System

Moujir Carolina Fernandez-Trujillo , Perez Carlos Antonio Rodriguez , Arencibia Dunia Marrero , Plasencia Yaiza Lopez , Zaballo Julio Perez , Galvan Jose Cabrera , Mogollon Francisco Javier Novoa , Cortes Mauro Boronat

Introduction: Fine needle aspiration biopsy (FNAB) is the mainstay diagnostic procedure for evaluation of thyroid nodules, but it doesn’t permit to distinguish between benign and malignant follicular lesions (category IV in the Bethesda Cytopathology System). Some reports have suggested an association between increased serum levels of TSH and thyroid cancer. However, the specific relationship between TSH and malignancy has been scarcely studied in follicu...

ea0099ep1014 | Adrenal and Cardiovascular Endocrinology | ECE2024

Adrenal cavernous hemangioma: a diagnostic challenge

Garcia Piorno Alberto , Losada Gata Isabel , Gomez-Gordo Hernanz Monica , Collado Gonzalez Gloria , Perez Noguero Marta , Jimenez Hernando Ignacio , Rivas Alejandra , Perez Lopez Gilberto , Gonzalez Fernandez Laura

Introduction: Cavernous hemangiomas (CH) are benign vascular tumors that frequently involve the skin, central nervous system or liver. Rarely, they can also affect adrenal glands. Adrenal cavernous hemangiomas are mostly unilateral lesions, typically discovered incidentally on radiological imaging. They generally present in the sixth to seventh decade of life and tend to be asymptomatic and non-functioning tumors. Preoperative differential diagnosis from malignant neoplasms ow...

ea0099ep143 | Pituitary and Neuroendocrinology | ECE2024

Pituitary neuroendocrine tumors in elderly patients: clinical and surgical outcomes in a tertiary hospital

Borrego Soriano Ines , Parra Ramirez Paola , Martin Rojas-Marcos Patricia , Perez Lopez Carlos , Garcia Feijoo Pablo , Lisbona Catalan Arturo , Vazquez Perez Paula , Cristina Alvarez Escola Maria

Introduction and aim: The current population is experiencing an increase in life expectancy, with a consequent change in the demographic structure of the society. It is common, therefore, to find elderly patients with pituitary neuroendocrine tumors (PitNET) in our usual clinical practice. Currently, there are no specific recommendations for treatment and data of outcomes in elderly are scarce. The aim of our study was to compare the clinical characteristics and surgical outco...

ea0081ep924 | Reproductive and Developmental Endocrinology | ECE2022

Recovery of hypothalamic-pituitary-gonadal function with low dose testosterone treatment in a male with idiopathic hypogonadotropic hypogonadism

Braca Fernando , Acosta Juan Carmelo Betancor , Martin Nuria Perez , Cortes Mauro Boronat

Idiopathic hypogonadotropic hypogonadism (IHH) is a rare congenital disease caused by deficiency or action of gonadotropin-releasing hormone. While generally considered a long-life condition, IHH can be reversible in about 20-30% of cases, but mechanisms of reversibility are unknown. We report the case of a male with IHH who began treatment with low dose (20 mg/day) transdermal testosterone to induce pubertal development at age 18. Following the start of treatment, he experien...

ea0050mte2 | Metabolomics and Diet | SFEBES2017

Modernazing dietary assessment by use of metabolic profiling

Garcia-Perez Isabel , Posma Joram M , Gibson Rachel , Chambers Edward S , Holmes Elaine , Frost Gary

A major limitation of nutritional science is the objective assessment of dietary intake in free-living populations. Monitoring individuals’ response to policy recommendations is based on self-reported dietary assessment tools, which are known to have high misreporting rates estimated at 30–88%. We have developed a novel analytical pipeline capable to classify people into consumers of a healthy or unhealthy diet based on urinary metabolic patterns, without relying on ...

ea0050mte2 | Metabolomics and Diet | SFEBES2017

Modernazing dietary assessment by use of metabolic profiling

Garcia-Perez Isabel , Posma Joram M , Gibson Rachel , Chambers Edward S , Holmes Elaine , Frost Gary

A major limitation of nutritional science is the objective assessment of dietary intake in free-living populations. Monitoring individuals’ response to policy recommendations is based on self-reported dietary assessment tools, which are known to have high misreporting rates estimated at 30–88%. We have developed a novel analytical pipeline capable to classify people into consumers of a healthy or unhealthy diet based on urinary metabolic patterns, without relying on ...

ea0090ep1157 | Late Breaking | ECE2023

Prevalence of MTHFR polymorphisms and metabolic outcomes in Chilean women with Polycystic Ovary Syndrome

Carrasco Matias , Calfunao Susan , Martinez Paz , Crisosto Nicolas , Salas-Perez Francisca

Background: Polycystic ovary syndrome (PCOS) is a prevalent and multifactorial endocrine disorder, characterized by reproductive and metabolic alterations. However, the mechanisms that contribute to the development of metabolic abnormalities are not completely understood. Interestingly, women with PCOS show changes in folate and homocysteine levels suggesting an altered folate metabolism, which could be associated to changes in the methylation patterns of metabolic genes. Meth...

ea0063gp161 | Cushing's | ECE2019

Ubiquitin-specific protease 8 (USP8) potentiates glucocorticoid receptor activity in corticotroph tumour cells

Perez-Rivas Luis , Ciato Denis , Colon-Bolea Paula , Reincke Martin , Theodoropoulou Marily

Cushing’s disease tumours bear activating mutations in the ubiquitin-specific-protease 8 gene (USP8) gene in 40-60% of cases. We have previously observed that patients with USP8 mutant tumours have smaller tumour size and show a better response to high dose (8mg) dexamethasone stimulation test compared to those with wild type USP8 (1). The aim of this study was to define the role of USP8 on glucocorticoid receptor (GR) in corticotroph tumour cells. We did experim...

ea0063gp224 | Adrenal and Neuroendocrine - Clinical (1) | ECE2019

Caffeine upregulates hepatic SHBG production by increasing adiponectin in white adipose tissue

Brianso-Llort Laura , Fuertes-Rioja Lidia , Perez Lorena Ramos , Hernandez Cristina , Simo Rafael , Selva David

Epidemiological studies have shown that caffeine increases plasma SHBG levels and also reduce the risk of type 2 diabetes. There are no reports describing any molecular mechanism by which caffeine regulates hepatic SHBG production. The aim of the present study was to explore whether caffeine regulates SHBG production and to determine the associated molecular mechanisms. For this purpose, in vitro and in vivo studies were performed using human HepG2 cells and ...

ea0063p240 | Pituitary and Neuroendocrinology 1 | ECE2019

Pituitary stalk interruption syndrome: an uncommon presentation

Eugenia Lopez Valverde Maria , Florencio Ojeda Luna , Martin Lopez Manuel , Isabel Rebollo Perez Maria

Pituitary stalk interruption syndrome (PSIS) is a rare clinical entity characterised by an absent or thin pituitary stalk, hypoplasia of the anterior pituitary gland, and ectopic location of the posterior pituitary on magnetic resonance imaging (MRI). Presentation is on early childhood or puberty and the most common hormonal deficiencies are growth hormone (GH) and gonadotropines. We present the case of a 28-year-old female patient who consulted after 2 years in secondary amen...